Figure 2. Adjusted prevalence of monitoring of clinical parameters from 2013 to 2022, stratified according to the remoteness of residence. Results based on logistic regression models adjusted for practice IRSAD, age, gender, patient IRSAD, smoking status and history of CVD or CKD. Sample size per year N2013=1280; N2014=1563; N2015=1871; N2016=2198; N2017=2571; N2018=3049; N2019=3557; N2020=4188; N2021=4873; N2022=5365. BMI, body mass index; CKD, chronic kidney disease; CVD, cardiovascular disease; IRSAD, Index of Relative Socioeconomic Advantage and Disadvantage. ***p<0.001; **p<0.01; *p<0.05.